We create value for our clients through expertise in research, interpretation, and communication
Case Studies
-
Developing an Early Value Story
VALUE STATEMENT DEVELOPMENT
We worked with Galytx to translate the anticipated mode-of-action benefits of its small molecule inhibitors of galectin-3 into economic messages.
-
Improved Equity of Care in Pressure Injury Management
MEDICAL AND SCIENTIFIC COMMUNICATIONS
We provided medical writing support to US-based medical device company Bruin Biometrics, which involved writing up the results of a quality improvement study.
-
Supporting Growth in the Drug Development Sector
STRATEGY DEVELOPMENT
We worked with the Biomarkers team at Medicines Discovery Catapult (MDC) to help them determine how to increase adoption of their services by the drug development community.
-
Clinical Insights to Support an Investment Round
STRATEGY DEVELOPMENT
We worked with the team at QV Bioelectronics to obtain opinions from clinicians about the clinical prospects of their treatment for glioblastoma.
-
Advancing Antimicrobial Innovations
STRATEGY DEVELOPMENT
We facilitated strategic planning workshops for Vitec Microgenix, a company dedicated to creating healthier indoor environments through innovative antimicrobial technologies.
-
Defining Value Proposition and Route to Market
MARKET RESEARCH
We worked with a UK-based medical device start-up to assess the clinical and commercial potential of their innovative non-invasive continuous glucose monitor.
-
Strategic Planning to Support NHS Sustainability
LAUNCH AND COMMERCIALISATION
We worked with the Centre for Sustainable Healthcare to obtain insights from stakeholders about the product-market fit of CSH’s programmes and the factors influencing their uptake.
-
Documenting the Natural History of a Rare Disease
MEDICAL AND SCIENTIFIC COMMUNICATIONS
We worked with the team at Salford Royal Hospital to review the data collected as part of a real‑world data study on the progression of arginase-1 deficiency in adults treated at the hospital.
-
Helping to Ensure Product-Market Fit
MARKET RESEARCH
We partnered with Medwise.ai to explore and expand the potential use cases for its advanced AI technology within the pharmaceutical industry.
-
Assessing AI Preparedness in Drug Discovery
STAKEHOLDER ENGAGEMENT
We collaborated with the Medicines Discovery Catapult to evaluate the UK drug discovery sector's preparedness for AI integration.
Testimonials
-
![]()
“Nexcea’s expertise in manuscript preparation and their ability to interpret our data helped with the successful submission of our study. Their understanding of our research needs was evident from the start. They were always available to assist with revisions and responses to reviewer comments, making the process much smoother for our team. I can recommend their services to anyone seeking support with medical publications.”
Dr Reena Sharma, Consultant Adult Metabolic Medicine, Salford Royal Hospital, Northern Care Alliance
-
![]()
“Nexcea were excellent to work with, and I highly recommend them. As a very early startup, we needed to gather insights from clinicians on our innovative approach to treating glioblastoma. Nexcea identified and interviewed key clinicians in the UK and USA, providing us with valuable information on patient pathways, unmet needs, and how our treatment could integrate with current practices. The feedback was crucial in refining our product development and gave us the validation we needed to successfully raise investment. The process was straightforward, and we gained exactly the insights we were looking for.”
Qasim Akhtar, Head of Business Development, QV Bioelectronics
-
![]()
"I had the pleasure of working with Nexcea on a key publication focused on the impact of Sub-Epidermal Moisture (SEM) technology, particularly its role in detecting pressure ulcers in patients with dark skin tones. Pressure ulcer detection has long been challenging in individuals with darker skin, and Bruin Biometrics' SEM Technology offers a ground-breaking solution by identifying tissue damage before visible signs appear. Paul Riley PhD, and Meg Smith PhD, brought a wealth of expertise, helping us effectively convey the clinical significance of SEM technology. Their ability to translate complex scientific concepts into a compelling and accessible narrative was invaluable. Thanks to their efforts, our publication reached a wide audience and highlighted a crucial advancement in patient care. I highly recommend Nexcea for their deep understanding of life sciences, professionalism, and commitment to delivering impactful results."
Dr Vignesh Iyer, Vice-President, Global Medical Affairs and Market Access, Bruin Biometrics
-
![]()
“Nexcea expertly supported drafting our report for Innovate UK, which involved coordinating interviews with industry professionals. Their exceptional organisational skills, clear communication, and ability to navigate complex project requirements were instrumental in delivering a high-quality outcome. Nexcea's professionalism and efficiency made the entire process smooth and successful.”
Dr Mark Pinches, Head of Informatics, Medicines Discovery Catapult
-
![]()
“Nexcea’s structured and pragmatic approach enabled us to translate our scientific advancements into an economic rationale. The insights provided have been valuable in shaping our commercial strategy.”
Karen Sullivan, CEO, Galytx
-
![]()
"It was a pleasure to work with Nexcea, they have extensive knowledge of the pharmaceutical industry and a great understanding of digital health technology. We wanted to explore applications of our AI technology in the life science industry. Nexcea identified and arranged meetings with multiple stakeholders from different companies in the industry, providing us with valuable information on pharma workflow, unmet needs, and how our AI could support current practices. The feedback was crucial in refining our product development."
Dr Keith Tsui, CEO, Medwise.ai
-
![]()
“It was really helpful working with Nexcea on understanding the market for some of our services. Not only was the report helpful to steer our approach but we were so involved in the process that our team learned some of the skills needed and we’ve been able to repeat the exercise under our own steam since. We certainly would recommend.”
Hazel Walsh, Clinical Transformation Programme Manager, The Centre for Sustainable Healthcare
-
![]()
“My experience with Nexcea has been exceptional. They excelled in devising a structured plan for us to assess the value of integrating clinical biomarker analysis into our services at Medicines Discovery Catapult. In addition to assembling a thorough plan, they successfully coordinated interviews, facilitated an advisory group, and constructed a comprehensive report containing decisive findings and recommendations for future steps.”
Gayle Marshall, Head of Biomarkers, Medicines Discovery Catapult
-
![]()
“Nexcea’s insights were crucial for our non-invasive continuous glucose monitor. The team promptly gathered feedback from specialists and provided NHS procurement guidance and economic analysis confirming our product's market fit and strategic NHS adoption path. Thank you for your exceptional support.”
CEO, UK-Based Medical Device Startup
-
![]()
“Nexcea’s workshops helped us crystallise our thinking and provided a clear structure for the next steps in our strategic development.”
Scott Perkins, CEO, Vitec Microgenix
Partners
